Dr Segal discusses future developments in biomarkers for multiple sclerosis, that could facilitate diagnosis, prognosis, and patient management.
Emerging biomarkers in multiple sclerosis
Dr Segal has listed no disclosures.
Dr Segal discusses future developments in biomarkers for multiple sclerosis, that could facilitate diagnosis, prognosis, and patient management.
Dr Segal has listed no disclosures.